Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial

Ron G. Rosenfeld, Raymond L. Hintz, Ann J. Johanson, Jo Anne Brasel, Stephen Burstein, Steven D. Chernausek, Teresa Clabots, James Frane, Ronald W. Gotlin, Joyce Kuntze, Barbara M. Lippe, Patrick C. Mahoney, Wayne V. Moore, Maria I. New, Paul Saenger, Elizabeth Stoner, Virginia Sybert

Research output: Contribution to journalArticle

63 Scopus citations

Abstract

Seventy girls with Turner syndrome, 4 to 12 years of age, were randomly assigned to receive either no treatment (control) or methionyl human growth hormone (0.125 mg/kg three times per week), oxandrolone (0.125 mg/kg/day), or combination hGH plus oxandrolone therapy. Baseline growth rates averaged 4.3 cm/yr, and all were within 2 SD of mean growth velocity for age in giris with Turner syndrome. Sixty-seven giris remained in the study for a minimum of 1 year. Growth rates and growth velocity (in standard deviations for age in girls with Turner syndrome) were control 3.8 cm/yr (-0.1 SD), hGH 6.6 cm/yr (+2.3 SD), oxandrolone 7.9 cm/yr (+3.7 SD), and combination therapy 9.8 cm/yr (+5.4 SD). Mean bone ages advanced 1.0 years (hGH), 1.3 years (oxandrolone), and 1.6 years (combination). However, median increments in height age/bone age (ΔHA/ΔBA) ratios ranged from 1.0 to 1.1 for treatment groups, compared with 0.8 for the controls. Predicted adult height by the method of Bayley-Pinneau increased 2.5 cm for hGH or oxandrolone alone, and 3.2 cm for combination treatment. These data indicate that both hGH and oxandrolone can significantly stimulate short-term skeletal growth in patients with Turner syndrome, and potentially increase final adult height.

Original languageEnglish (US)
Pages (from-to)936-943
Number of pages8
JournalThe Journal of pediatrics
Volume109
Issue number6
DOIs
StatePublished - Dec 1986

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial'. Together they form a unique fingerprint.

  • Cite this

    Rosenfeld, R. G., Hintz, R. L., Johanson, A. J., Brasel, J. A., Burstein, S., Chernausek, S. D., Clabots, T., Frane, J., Gotlin, R. W., Kuntze, J., Lippe, B. M., Mahoney, P. C., Moore, W. V., New, M. I., Saenger, P., Stoner, E., & Sybert, V. (1986). Methionyl human growth hormone and oxandrolone in Turner syndrome: Preliminary results of a prospective randomized trial. The Journal of pediatrics, 109(6), 936-943. https://doi.org/10.1016/S0022-3476(86)80272-4